Drugs that contain Pasireotide Diaspartate
1. List of Signifor drug patents
Can you believe SIGNIFOR received compensation for the extended wait time during the regulatory approval process?
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8299209 | RECORDATI RARE | Pharmaceutical composition comprising cyclic somatostatin analogues |
Dec, 2025
(2 years from now) | |
| US7473761 | RECORDATI RARE | Somatostatin analogues |
Dec, 2026
(3 years from now) | |
Market Authorisation Date: 14 December, 2012
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
SIGNIFOR family patents
9
United States
4
European Union
3
United Kingdom
3
Norway
3
Korea, Republic of
3
Australia
2
Portugal
2
Germany
2
Malaysia
2
Russia
2
Spain
2
Brazil
2
New Zealand
2
Austria
2
Argentina
2
Mexico
2
Peru
2
China
2
Taiwan, Province of China
2
Hong Kong
2
South Africa
2
Japan
2
Canada
2
Cyprus
2
Slovenia
2
Israel
2
Poland
2
Ecuador
2
Denmark
1
Croatia
1
Colombia
1
Morocco
1
Belgium
1
Tunisia
1
Slovakia
1
Hungary
1
Luxembourg
1
Czech Republic
1
Iceland
1
Chile
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic